Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
about
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsOxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial AgentsCulture-independence for surveillance and epidemiologyReview of Antibiotic Resistance in the Indian Ocean Commission: A Human and Animal Health Issue.Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Population distribution of Beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands.Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.Pseudomonas aeruginosa: resistance to the maxAmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa.Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010Comparison of Extended-Spectrum β-Lactamase (ESBL) CTX-M Genotypes in Franklin Gulls from Canada and ChileInteraction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosaEvaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibioticsIncidence, Clinical Outcome and Risk Factors of Intensive Care Unit Infections in the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Molecular Epidemiology of ESBL Genes and Multi-Drug Resistance in Diarrheagenic Escherichia Coli Strains Isolated from Adults in IranMutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa.Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model.Profile of micro-organisms in intensive care unit of a level-1 trauma centre: A retrospective study.In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals in the CANWARD study, 2007 to 2012.Population-based surveillance for hypermucoviscosity Klebsiella pneumoniae causing community-acquired bacteremia in Calgary, Alberta.In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates.Prevalence and incidence of antimicrobial-resistant organisms among hospitalized inflammatory bowel disease patients.Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Methicillin-resistant staphylococci: implications for our food supply?Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more.The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study.Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity.Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection.Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.Usefulness of previous methicillin-resistant Staphylococcus aureus screening results in guiding empirical therapy for S aureus bacteremia.Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia.Molecular epidemiology and mechanisms of antimicrobial resistance in Pseudomonas aeruginosa isolates causing burn wound infection in Iran.Novel arrangement of the blaCTX-M-55 gene in an Escherichia coli isolate coproducing 16S rRNA methylase.
P2860
Q26782924-962FBD31-058C-47DB-A614-DB8F7B1B3B59Q27644560-90D4BCD5-57E7-4F39-B9F9-182D9BBE2F03Q28652027-DC6CE005-DEDA-4AE4-8916-4A753D67D131Q33876254-8AE5610D-B1D5-46C5-9A51-2EFF35CE4ED7Q34386310-6293E4FF-85B3-4051-A97E-59B1404231DDQ34446914-08345DD0-AC85-4012-AA02-8EA454E0F1A5Q34532991-9EECFDA5-54ED-4D84-A7AB-1030EBCF0E0CQ35065834-579B0F0B-AB3C-4B86-BB3C-8ACA1B1DBEA4Q35084559-5C475BA1-7C72-4B26-AFA3-760BA3746D63Q35106217-036A958E-EA20-4C89-8E61-82293FDF8344Q35806428-DFECB5D2-6E7D-4E8A-9DD2-3AE2CADAA4C5Q35819191-B3A0E37C-5F1B-484D-9126-A42DB81FC556Q35830489-D50D7A14-58AB-44A3-8528-3C34263AB8B4Q36035185-638EC77E-F7BD-4055-916C-451EC251DAEFQ36167152-1DF31140-84F2-40AD-B8C2-7DE438D78B5AQ36173140-84749EF6-92EE-4FBF-8637-46F50002ABB2Q36337074-BC60E1B6-0E68-4254-8EF5-BBD9D6F3D172Q36358424-96C615D2-B25A-42E0-94D4-44603A32F57FQ36785893-6D7BC6EF-BE86-4B01-979E-1DB4317E2149Q36969966-1A5D5481-4DFA-489E-A610-A0832C4344DBQ37119702-213D48B6-7A6E-4E35-9AE5-B7DED32AFC2CQ37263317-5BEB0BCD-5BFA-48FC-9A30-D45C47290503Q37366777-4F18D4A1-469B-4A4E-8DC0-49DDEF855744Q37409945-2022E230-609E-4DF9-8FBC-98D3924065D4Q37525670-6F185E44-ACD1-459D-80E7-41B5E06BA051Q37924980-4C76EBD3-B879-49B0-B884-D9A9A582D2B9Q37998398-1A12FF0B-BE93-4DA6-AD34-EB6B0191C452Q38068576-D1AD3509-CDF5-4A11-8103-8A2DFF771AC9Q38099393-6AAE58AE-F01F-4E2C-8DDB-21A4F858D8E4Q38267242-2D2894EC-5F59-4710-B390-7BF686B7E442Q38497797-F6C7D029-EBF9-4364-B120-BD021E2ACCF8Q38849468-D60F70DA-1833-412B-B14C-49AED97EB07FQ38970950-98904E80-81CE-4D82-A28E-5E37D84CEB87Q39501803-7E9E500D-FEA3-467F-B1D4-D5B80D9AF001Q39678348-B220377E-3ACC-4974-AC5B-F847DFF205E6Q40358195-E8F567AA-1623-4E44-9212-418BAF0C5457Q41004977-4E56B500-2D88-4702-9074-78D65DBF1A3FQ41104461-9B18FAEB-01EF-483A-BD45-E4FDB820EC04Q42246427-6DC9F9EF-A0FF-446A-BBFD-2C0EBA585D44Q45160990-3B41F2A4-9963-4FE0-98B3-722D24BC4856
P2860
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevalence of antimicrobial-re ...... eillance Study (CANWARD 2008).
@ast
Prevalence of antimicrobial-re ...... eillance Study (CANWARD 2008).
@en
Prevalence of antimicrobial-re ...... nadian Ward Surveillance Study
@nl
type
label
Prevalence of antimicrobial-re ...... eillance Study (CANWARD 2008).
@ast
Prevalence of antimicrobial-re ...... eillance Study (CANWARD 2008).
@en
Prevalence of antimicrobial-re ...... nadian Ward Surveillance Study
@nl
prefLabel
Prevalence of antimicrobial-re ...... eillance Study (CANWARD 2008).
@ast
Prevalence of antimicrobial-re ...... eillance Study (CANWARD 2008).
@en
Prevalence of antimicrobial-re ...... nadian Ward Surveillance Study
@nl
P2093
P2860
P356
P1476
Prevalence of antimicrobial-re ...... veillance Study (CANWARD 2008)
@en
P2093
Aleksandra Wierzbowski
Andrew Walkty
Canadian Antimicrobial Resistance Alliance
Daryl J Hoban
Franil Tailor
Frank Schweizer
Heather Adam
Jack Johnson
James A Karlowsky
Kimberly A Nichol
P2860
P304
P356
10.1128/AAC.00469-10
P407
P577
2010-08-30T00:00:00Z